Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageBalchem Corporation (“Balchem,” the “Company,” “we” or “us”), was incorporated in the State of Maryland in 1967. We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. Our three reportable segments are strategic businesses that offer products and services to different markets: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
In the company’s own words · 10-K filed Feb 20, 2026 · SEC EDGAR
Business segments
Q1 2026 · $270.7MThe company’s own SEC segment disclosure.
- Product Sales$270.2M100%
- Royalty$493.0K0%
Balchem Corporation (BCPC) reported revenue of $271M in Q1 2026 (quarter ended March 31, 2026), up 8.1% from the same quarter a year earlier. That came with a gross margin of 37% and net income of $40M (15% of revenue). For the full year FY2025, revenue was $1.04B (+8.8% year on year) and net income $155M. Its largest product in 2026-Q1 was Product Sales at $270M, 100% of the disclosed total, just ahead of Royalty at 0.2%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.